APA (7th ed.) Citation

J, L., J, G., Z, J., W, L., P, Z., X, L., & B, L. (2026). Hydroxysafflor Yellow A improves diabetic nephropathy by inhibiting PI3K/AKT/mTOR pathway based on a multidimensional study. Frontiers in medicine, 13, 1747346. https://doi.org/10.3389/fmed.2026.1747346

Chicago Style (17th ed.) Citation

J, Liu, Gao J, Jiang Z, Li W, Zhang P, Liu X, and Lyu B. "Hydroxysafflor Yellow A Improves Diabetic Nephropathy by Inhibiting PI3K/AKT/mTOR Pathway Based on a Multidimensional Study." Frontiers in Medicine 13 (2026): 1747346. https://doi.org/10.3389/fmed.2026.1747346.

MLA (9th ed.) Citation

J, Liu, et al. "Hydroxysafflor Yellow A Improves Diabetic Nephropathy by Inhibiting PI3K/AKT/mTOR Pathway Based on a Multidimensional Study." Frontiers in Medicine, vol. 13, 2026, p. 1747346, https://doi.org/10.3389/fmed.2026.1747346.